Telescope Innovations Expands Lithium Development Infrastructure and Achieves Key Material Validation Milestones Ready to Announce with Confidence?
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a leader in Physical AI, Self-Driving Laboratories, and other enabling technology to support autonomous laboratory infrastructure. The Company is pleased to provide an update on the progress of its lithium processing portfolio. Our focus remains on securing a sustainable, on-shore supply of critical battery materials through our proprietary DualPure™ and ReCRFT™ technologies.
FACILITY EXPANSION: ENHANCING LITHIUM R&D CAPABILITY
To support the development of our lithium programs, Telescope has secured a lease for additional laboratory and scale-up space.
ReCRFT™: VALIDATION IN BATTERY RECYCLING
Our ReCRFT™ (Recrystallization Refinement Technology) is demonstrating its ability to produce battery-grade Lithium Carbonate (Li 2CO 3) from recycled streams.
DualPure™: ADVANCING THE SOLID-STATE SUPPLY CHAIN
The DualPure™ process offers a novel, low-temperature route to high-purity Lithium Sulfide (Li 2S), a critical component for next-generation solid-state batteries.
MOVING FORWARD
With an expanded physical footprint and successful material validation, Telescope is well-positioned as a technology provider in the lithium materials space. We look forward to providing further updates as we complete the commissioning of our new UBC facility and progress our commercial discussions.
"Today's milestones strengthen Telescope's position as a key technology provider in the North American lithium supply chain," said Henry Dubina, Telescope CEO. "With our UBC facility expansion and the validation of our ReCRFT™ and DualPure™ processes, we're demonstrating how Physical AI and Self-Driving Labs can accelerate the development of advanced processes for manufacturing battery materials."
About Telescope Innovations
Telescope Innovations Corp. is a developer of intelligent automation and advanced chemical manufacturing technologies. The Company builds and deploys enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality across the health and sustainability sectors. For more information, please visit www.telescopeinnovations.com.
On behalf of the Board,
Telescope Innovations Corp.
Henry Dubina, Chief Executive Officer
E: henry.dubina@telescopeinn.com
T: 778-262-1166
Forward-Looking Information
The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain certain "forward-looking information" under applicable Canadian securities laws. When or if used in this news release, the words "anticipate," "believe," "estimate," "expect," "intend," "target," "plan," "forecast," "may," "schedule," "aim," and similar words or expressions identify forward-looking information.
Forward-looking information is based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information.
The forward-looking information contained in this news release is made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/281757
Source: Telescope Innovations Corp.
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Telescope Innovations Corp. or all companies in the Technology, Chemical, Pharmaceuticals industry.
Telescope Strengthens Investor Communications Strategy
2026-03-12 8:30 AM EDT
Telescope Innovations Installs Second Self-Driving Lab at Pfizer
2026-02-23 8:00 AM EST
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026
2026-01-30 7:28 PM EST
Sep 29, 2025
AI isn’t just a future trend. It’s already reshaping how press releases are read, shared, and discovered today. The audience for your news is no longer only human. Journalists, analysts, and investors still matter, but now AI systems are scanning, indexing, and summarizing your announcements at scale. Here are a few numbers that show the size of this shift: 78% of companies now use AI in at least one function ( McKinsey, 2025 ) 92% of Fortune 500 companies are using OpenAI's technology (...
Economy, Business and Finance
Chemicals
Pharmaceutical
Science and Technology
Research and Development
Technology
Chemical
Pharmaceuticals